MIA
GILD icon

MainStreet Investment Advisors’s Gilead Sciences GILD Stock Holding History

MainStreet Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,855
Closed -$527K – 201
2020
Q2 		$527K Sell
6,855
-667
-9% -$51.1K 0.04% 175
2020
Q1 		$562K Buy
+7,522
New +$520K 0.07% 146

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

MainStreet Investment Advisors's GILD Position: Q3 2020 in Review

MainStreet Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 6,855 shares — an estimated $527K sold.

MainStreet Investment Advisors first reported a position in GILD in Q1 2020 and held it in 2 quarters. The position peaked at $562K in Q1 2020. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • MainStreet Investment Advisors reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • MainStreet Investment Advisors sold 6,855 Gilead Sciences shares in Q3 2020, an estimated $527K.
  • MainStreet Investment Advisors first reported a position in Gilead Sciences in Q1 2020 and held it in 2 quarters.
  • MainStreet Investment Advisors's Gilead Sciences position peaked at $562K in Q1 2020.
  • 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on MainStreet Investment Advisors's 13F filing for Q3 2020, filed 9 Nov 2020.